ABP-450 + Placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
44
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Cervical Dystonia
Conditions
Cervical Dystonia
Trial Timeline
Mar 29, 2021 → Jul 11, 2022
NCT ID
NCT04849988About ABP-450 + Placebo
ABP-450 + Placebo is a phase 2 stage product being developed by AEON Biopharma for Cervical Dystonia. The current trial status is completed. This product is registered under clinical trial identifier NCT04849988. Target conditions include Cervical Dystonia.
Hype Score Breakdown
Clinical
17
Activity
12
Company
2
Novelty
5
Community
5
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04849988 | Phase 2 | Completed |
| NCT04845178 | Phase 2 | Completed |
Competing Products
20 competing products in Cervical Dystonia